Exscientia
✓ Verified
Healthcare AI
AI drug discovery and precision medicine
Acquired
Exscientia is an AI-driven drug discovery and precision medicine company that used artificial intelligence and automation to design and develop small-molecule therapies, with a focus on oncology and other therapeutic areas; it became known for advancing AI-designed drugs into human clinical trials and later merged into Recursion in 2025.
Company Details
- Website
- exscientia.ai
- Headquarters
- Oxford, United Kingdom
- Founded
- 2012
- Funding
- ~$1.1B
Subscriber Intelligence
- • Deal signal alerts for this company
- • Sentiment & risk scoring
- • Competitive framework analysis
- • Regulatory event monitoring